VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of betting on a single drug pipeline. Right now, that ...
TrumpRx/MFN pricing risks could pressure margins despite 9.3x fwd P/E, 6.27% dividend and pipeline gains. Read the latest ...
Jim Cramer reviewed Pfizer Inc. (NYSE:PFE) while breaking down 16 stocks for a market facing higher energy costs and economic ...
OpenText stock is down 55% but this Canadian tech giant is quietly building one of the best AI infrastructure plays in ...
Newsworthy Women on MSN
Senator caught breaking stock law she championed
For more than a decade, Susan Collins positioned herself as a defender of transparency in Washington — a supporter of efforts ...
Pfizer started 2026 on a high note despite ongoing skepticism from retail investors. Click here to find out why PFE stock is ...
The Republican senator missed a 45-day deadline for revealing her husband bought up to $50,000 in Pfizer corporate bonds.
Pfizer (NYSE: PFE) is one of the most widely held dividend stocks among retirement investors. The stock currently yields 6.3% ...
In 2025, we made significant strides towards advancing DrugSorb-ATR - a two-time U.S. Food and Drug Administration (FDA) Breakthrough Device - through the FDA De Novo submission process to reduce ...
After years of lagging the market, has Pfizer (PFE +1.19%) finally found a spark? With unimpressive financial results and ...
Shares of C4 Therapeutics rose after the company dosed its first patient in a Phase 1b trial for a multiple myeloma treatment. Shares were up 6.6% to $2.67 in Wednesday afternoon trading. The stock is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results